Bristol Myers Squibb Co has signalled a commitment to artificial intelligence with a strategic agreement with Anthropic PBC to deploy the AI tool Claude across the company’s research, clinical development, manufacturing, commercial and corporate functions. Announced on 20 May, the agreement will make the technology available to more than 30,000 BMS employees. The financial terms of the agreement were not disclosed.
